Dr. Aliakbar Arvandi - NPI #1245424415

Cardiovascular Disease Doctor located in Lubbock, TX

Texas Lubbock Cardiovascular Disease Dr. Aliakbar Arvandi Information

About

Dr. Aliakbar Arvandi is a male Cardiovascular Disease Doctor (taxonomy code 207RC0000X) located in Lubbock, Texas. Dr. Aliakbar Arvandi primarily specializes in Cardiovascular Disease but also specializes in and Internal Medicine. Dr. Aliakbar Arvandi's NPI Number is #1245424415 and has been listed in the NPI registry for 10 years. Dr. Aliakbar Arvandi's practice location is listed as: 3601 4Th St Lubbock, TX 79430-9410 and can be reached via phone at (806) 743-3150.

Cardiovascular Disease Taxonomy

The taxonomy code for Dr. Aliakbar Arvandi's main specialty, Cardiovascular Disease, is 207RC0000X. An internist who specializes in diseases of the heart and blood vessels and manages complex cardiac conditions such as heart attacks and life-threatening, abnormal heartbeat rhythms.

Map

Ratings

Be the first to rate Dr. Arvandi

Overall
Professionalism
Facilities
Availability
Thanks for sharing your opinion!

‡ Descriptions, provider messages, and reviews are user submitted. While we make our best effort to verify the accuracy of information submissions, DocBios cannot guarantee that the information is accurate and/or up to date. Please verify any and/or all information with the provider. DocBios is not an advice or referral service and does not guarantee, approve, or endorse any particular healthcare provider.

Health Care Provider Information
 NPI # 1245424415
 Phone (806) 743-3150
 Fax (806) 743-3168
 Address
3601 4Th St
Lubbock, TX 79430-9410
 Gender M
 Website Not provided
Specialties
  • Cardiovascular Disease (TX)
  • Internal Medicine (TX)
Business Information
  • Sole Proprietor? No
  • Is Sub-Organization? Not Available
  • Parent Org Name: Not Available
 Updated 2/12/2014
 Added 8/30/2007
 Viewed on 7/22/2017
Health Care Providers Nearby
Success

Thanks! Your edit was sucessfully submitted. Changes will be displayed after DocBios.com editors have reviewed your submission.